This document discusses ReproSci Biosciences Private Limited's goal of helping 1 million couples achieve parenthood by 2030 through assisted reproductive technology. It describes their medical training simulator called Fertilator, which uses haptic and virtual reality technologies to train practitioners in fertility procedures like oocyte retrieval and embryo transfer. Fertilator aims to address the large increase in fertility specialists needed globally to provide affordable and accessible infertility care.

1. ReproSci Biosciences Private Limited
Elevating 1,000,000 Couples to Parenthood by 2030
2021 © Reprosci Biosciences Private Limited
01

3. Surgical Simulation Market by Offering (Products [Laparoscopic, Endoscopic, Neurological,
Gynaecological, Cardiac, Arthroscopic], Services [Educational, Technical]), by End User
(Academic & Research Institutes, Hospitals, Surgical Clinics, Military Organizations), by
Geography (U.S., Canada, Germany, France, U.K., Italy, Spain, Japan, China, India) – Global
Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023
GLOBAL SURGICAL SIMULATION MARKET, BY OFFERING, $M (2013-2023)
07

4. Japan, Russia, & Italy are among number of countries that are already facing negative population growth.
Over 20 other countries are rapidly moving towards a similar crisis. A large number of these countries
have taken up fertility care as a public health priority & cumulatively funding billions.
Indian Market for Medical Education & Training (MET) in Assisted Reproductive Technology (ART): India has about 3000
Fertility Specialist & this number has to increase 3 to 4 times in 5-7 years largely in the Public Health Systems.
We’ll contribute to the following recommendations of EY Report:
 Directly (2) & (4)
 indirectly to (5) & (6)
with growing awareness & emphasis on patient safety, the traditional methods of medical education &
training (MET) is being disrupted!
08

5. Fertilator is a Medical Training Simulator meant to be used as a Comprehensive Training and
Credentialing System for practicing Assisted Reproductive Technology (ART) procedures
Introducing World’s 1st Haptic + VR Simulator for training and pre-Operative planning ART Procedures
Hardware:
1. Standalone Unit
 Haptic Feedback
 Sensors
2. Probe, Catheter, Needle
3. Footswitch
4. Oculus, Remote, Sensors
5. Display
Comes in two Variants:
1. Standard: 3D VR, Haptic
Control
2. Desktop: 2D, Mouse, Keyboard
Scenarios:
1. Oocyte Retrieval
2. Embryo Transfer
Can be practiced in two ways:
1. Real-time OT environment.
2. Anatomy based for improved hand eye
coordination.
Oocyte Retrieval:
1. 3D model based ultrasound
simulation with Probe (6 DoF) and
Lumen (1DoF).
2. Haptic feedback: Lumen piercing force
feedback at vaginal wall, ovary and
follicle.
3. Real time tissue deformation.
4. Follicle aspiration using footswitch
Embryo Transfer:
1. Plunger pressure gauge.
Specification / Features of Fertilator
09

6. Fig 3: Ultrasound simulation of Oocyte Retrieval
Fig 2: Embryo Transfer using plunger Fig 4: Embryo Transfer using plunger
Fig 1: Medical Simulator - Fertilator, which contains a hardware unit (White box), Display Monitor
Medical Procedures/Features supported by Fertilator Ver. Fertilator PickUpSim TransferSim
Oocyte Retrieval 1   
Embryo Transfer (ET) & Intra uterine insemination (IUI) 1   
LMS Integration Service 1   
Learner Assessment/Credentialing 1   
Ultrasound trainer 2   
Hysteroscopy (diagnostic) 2   
 Fertilator v1 includes Four key features/functions as
mentioned in the following table
 We’re currently developing the hysteroscopy module for
diagnostic training
 LMS Integration will enable the tracking of all the
learnings activities and progress of the trainee in the LMS.
 Working towards finalizing a multicentre, randomized
controlled clinical trial in India & Europe
FERTILATOR has a Technology Readiness Level of 8 (TRL Level 8)
10

7.  Considering the number of fertility specialist will have to be TRIPLED within Five to Seven years, Fertilator will
cater to the globally increasing need & demand for fertility care both in Private & Public Health Systems.
 While our venture is primary driven by profitability considering that about 70% of infertile couple in developing
Countries cannot afford the expensive treatment our technology stack will be intended to be Affordable &
Accessible.
 General perception is that India is overpopulated but the reality is that it’s a myth with India reaching replacement
levels of fertility by 2020. Similar to India many would presume that China is also overpopulated but the two-child
policy rolled out by China indicates that perception is not a reality.
With the rapidly expanding public health service for Infertility care around the world, the need for
training 10’s of 1000’s of fertility specialist every year will be addressed using FERTILATOR. This will
ensure that Safe, Affordable & Accessible Infertility care can be provided to
Millions globally.
 Social Impact: With about 30 Million infertile couples in India most of whom cannot afford
expensive ART treatment, completing their families with a child helps in creating a happier society.
 Economic Impact: Ensuring that the national population is about the replacement levels a
significant economic impact is achieved with sustaining or even growing GDP.
11

8. 2021 © Reprosci Biosciences Private Limited
Indian IVF Market Size Report from 2014 that has grown multiple times over since
12

10. Dr. Ravi S Swamy, Director, ravi@reprosci.health, +91 96117 31122
Vijaygopal R, Chief Innovation Officer, vijay@reprosci.health, +91 95135 13009
Reprosci Biosciences Private Limited
NASSCOM CoE IoT, KEONICS, #29/A (E), 3rd Floor, 27th Main,
7th Cross Rd, 1st Sector, HSR Layout, Bengaluru - 560 102. KA, IN
BioNEST at IKP EDEN, 16, Bhuvanappa Layout,
Tavarekere Main Rd, Bengaluru, 560029. KA, IN
corp.comm@reprosci.health | www.reprosci.health